TW216797B - - Google Patents

Info

Publication number
TW216797B
TW216797B TW080108674A TW80108674A TW216797B TW 216797 B TW216797 B TW 216797B TW 080108674 A TW080108674 A TW 080108674A TW 80108674 A TW80108674 A TW 80108674A TW 216797 B TW216797 B TW 216797B
Authority
TW
Taiwan
Application number
TW080108674A
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of TW216797B publication Critical patent/TW216797B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW080108674A 1990-10-12 1991-11-02 TW216797B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59681190A 1990-10-12 1990-10-12

Publications (1)

Publication Number Publication Date
TW216797B true TW216797B (zh) 1993-12-01

Family

ID=24388816

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080108674A TW216797B (zh) 1990-10-12 1991-11-02

Country Status (7)

Country Link
EP (1) EP0552297A1 (zh)
JP (1) JPH06502075A (zh)
KR (1) KR930702506A (zh)
AU (1) AU663064B2 (zh)
CA (1) CA2093919A1 (zh)
TW (1) TW216797B (zh)
WO (1) WO1992007001A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0556320T3 (da) * 1990-11-07 1999-10-18 Abbott Lab Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
ES2377968T3 (es) 2003-04-01 2012-04-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Anticuerpos dirigidos contra el complejo E1E2 del virus de la hepatitis C y composiciones farmacéuticas
NZ579706A (en) 2007-02-21 2012-03-30 Univ Massachusetts Human antibodues against hepatitis C virus (HCV) E2 protein and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU216017B (hu) * 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
AU632271B2 (en) * 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver

Also Published As

Publication number Publication date
WO1992007001A1 (en) 1992-04-30
AU663064B2 (en) 1995-09-28
CA2093919A1 (en) 1992-04-13
JPH06502075A (ja) 1994-03-10
AU8945791A (en) 1992-05-20
KR930702506A (ko) 1993-09-09
EP0552297A1 (en) 1993-07-28
EP0552297A4 (zh) 1994-02-09

Similar Documents

Publication Publication Date Title
FR2666464B1 (zh)
DE4190992T (zh)
DE4190941T (zh)
DE4192071T (zh)
EP0486635A4 (zh)
FR2663349B1 (zh)
DE4092522T (zh)
FR2664811B1 (zh)
FR2662620B1 (zh)
EP0507951A4 (zh)
FR2666699B1 (zh)
FR2660741B1 (zh)
DE4191772T (zh)
FR2662084B1 (zh)
DE4192508T (zh)
FR2664537B1 (zh)
FR2660798B1 (zh)
FR2670461B1 (zh)
DE4190457T1 (zh)
TW216797B (zh)
FR2659410B1 (zh)
FR2663841B1 (zh)
DE4191099T (zh)
FR2663831B1 (zh)
ECSM90481U (zh)